Data Offer New Insights into AML.
A recently released dataset from a large cohort of patients with acute myeloid leukemia integrates genomic information about tumor samples with data on how cancer cells respond to drugs. The dataset, which will inform the Beat AML Master Trial, offers new insights into the disease, while providing information that will drive additional research efforts.